28
Views
3
CrossRef citations to date
0
Altmetric
Review

Abdominal aortic aneurysm screening: 2006 recommendations

&
Pages 555-561 | Published online: 09 Jan 2014

References

  • Johnston KW, Rutherford RB, Tilson MD et al. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J. Vasc. Surg.13(3), 452–458 (1991).
  • Lederle FA, Johnson GR, Wilson SE et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann. Intern. Med.126(6), 441–449 (1997).
  • Fleming C, Whitlock EP, Beil TL et al. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force. Ann. Intern. Med.142(3), 203–211 (2005).
  • Lederle FA, Johnson GR, Wilson SE. Aneurysm Detection and Management Veterans Affairs Cooperative Study. Abdominal aortic aneurysm in women. J. Vasc. Surg.34(1), 122–126 (2001).
  • Darling RC, Messina CR, Brewster DC et al. Autopsy study of unoperated abdominal aortic aneurysms. The case for early resection. Circulation56(Suppl. 3), 161–164 (1977).
  • Kantonen I, Lepantalo M, Brommels M et al. Mortality in ruptured abdominal aortic aneurysms. The Finnvasc Study Group. Eur. J. Vasc. Endovasc. Surg.17(3), 208–212 (1999).
  • Earnshaw JJ, Shaw E, Whyman MR et al. Screening for abdominal aortic aneurysms in men. Br. Med. J.328(7448), 1122–1124 (2004).
  • Office of Population Census and Surveys Mortality statistics: cause, England and Wales 1993. HMSO, London, UK (1995).
  • Hak E, Balm R, Eikelboom BC et al. Abdominal aortic aneurysm screening: an epidemiological point of view. Eur. J. Vasc. Endovasc. Surg.11(3), 270–278 (1996).
  • Wassef M, Baxter BT, Chisholm RL et al. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung and Blood Institute. J. Vasc. Surg.34(4), 730–738 (2001).
  • Tilson MD 3rd. The polymorphonuclear leukocyte and the abdominal aortic aneurysm: a neglected cell type and a neglected disease. Circulation112(2), 154–156 (2005).
  • Grange JJ, Davis V, Baxter BT. Pathogenesis of abdominal aortic aneurysm: an update and look toward the future. Cardiovasc. Surg.5(3), 256–265 (1997).
  • Shah PK. Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation96(7), 2115–2117 (1997).
  • Woodrum DT, Ford JW, Ailawadi G et al. Gender differences in rat aortic smooth muscle cell matrix metalloproteinase-9. J. Am. Coll. Surg.201(3), 398–404 (2005).
  • Schirmer M, Duftner C, Seiler R et al. Abdominal aortic aneurysms: an underestimated type of immune-mediated large vessel arteritis? Curr. Opin. Rheumatol.18(1), 48–53 (2006).
  • Shibamura H, Olson JM, van Vlijmen-Van Keulen C et al. Genome scan for familial abdominal aortic aneurysm using sex and family history as covariates suggests genetic heterogeneity and identifies linkage to chromosome 19q13. Circulation109(17), 2103–2108 (2004).
  • Alcorn HG, Wolfson SK Jr, Sutton-Tyrrell K et al. Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Biol.16(8), 963–970 (1996).
  • Naydeck BL, Sutton-Tyrrell K, Schiller KD et al. Prevalence and risk factors for abdominal aortic aneurysms in older adults with and without isolated systolic hypertension. Am. J. Cardiol.83(5), 759–764 (1999).
  • Biondi-Zoccai GG, Abbate A, Liuzzo G et al. Atherothrombosis, inflammation, and diabetes. J. Am. Coll. Cardiol.41(7), 1071–1077 (2003).
  • Fuster V, Gotto AM Jr. Risk reduction. Circulation102(20 Suppl. 4), IV94–IV102 (2000).
  • Darling RC. Ruptured arteriosclerotic abdominal aortic aneurysms. A pathologic and clinical study. Am. J. Surg.119(4), 397–401 (1970).
  • Limet R, Sakalihassan N, Albert A. Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms. J. Vasc. Surg.14(4), 540–548 (1991).
  • Brown LC, Powell JT. Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK Small Aneurysm Trial Participants. Ann. Surg.230(3), 289–296 (1999).
  • Kleinstreuer C, Li Z. Analysis and computer program for rupture-risk prediction of abdominal aortic aneurysms. Biomed. Eng. Online10(5), 19 (2006).
  • Fillinger MF, Marra SP, Raghavan ML et al. Prediction of rupture risk in abdominal aortic aneurysm during observation: wall stress versus diameter. J. Vasc. Surg.37(4), 724–732 (2003).
  • Scott RA, Ashton HA, Kay DN. Abdominal aortic aneurysm in 4237 screened patients: prevalence, development and management over 6 years. Br. J. Surg.78(9), 1122–1125 (1991).
  • Cassar K, Godden DJ, Duncan JL. Community mortality after ruptured abdominal aortic aneurysm is unrelated to the distance from the surgical centre. Br. J. Surg.88(10), 1341–1343 (2001).
  • Huber TS, Wang JG, Derrow AE et al. Experience in the United States with intact abdominal aortic aneurysm repair. J. Vasc. Surg.33(2), 304–310 (2001).
  • Norman PE, Semmens JB, Lawrence-Brown MM et al. Long term relative survival after surgery for abdominal aortic aneurysm in Western Australia: population based study. Br. Med. J.317(7162), 852–856 (1998).
  • Greenhalgh RM, Brown LC, Kwong GP et al. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet364(9437), 843–848 (2004).
  • Maher MM, McNamara AM, MacEneaney PM et al. Abdominal aortic aneurysms: elective endovascular repair versus conventional surgery-evaluation with evidence-based medicine techniques. Radiology228(3), 647–658 (2003).
  • Arko FR, Filis KA, Seidel SA et al. How many patients with infrarenal aneurysms are candidates for endovascular repair? The Northern California experience. J. Endovasc. Ther.11(1), 33–40 (2004).
  • Lederle FA, Simel DL. The rational clinical examination. Does this patient have abdominal aortic aneurysm? JAMA281(1), 77–82 (1999).
  • Wilmink AB, Forshaw M, Quick CR et al. Accuracy of serial screening for abdominal aortic aneurysms by ultrasound. J. Med. Screen.9(3), 125–127 (2002).
  • Lindholt JS, Vammen S, Juul S et al. The validity of ultrasonographic scanning as screening method for abdominal aortic aneurysm. Eur. J. Vasc. Endovasc. Surg.17(6), 472–475 (1999).
  • Lindholt JS, Juul S, Fasting H et al. Hospital costs and benefits of screening for abdominal aortic aneurysms. Results from a randomised population screening trial. Eur. J. Vasc. Endovasc. Surg.23(1), 55–60 (2002).
  • Scott RA, Wilson NM, Ashton HA et al. Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study.Br. J. Surg.82(8), 1066–1070 (1995).
  • Norman PE, Jamrozik K, Lawrence-Brown MM et al. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. Br. Med. J.329(7477), 1259 (2004).
  • Ashton HA, Buxton MJ, Day NE et al. Multicentre Aneurysm Screening Study Group. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet360(9345), 1531–1539 (2002).
  • Hirsch AT, Haskal ZJ, Hertzer NR et al; ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation113(11), E463–E654 (2006).
  • Rembold CM. Number needed to screen: development of a statistic for disease screening.Br. Med. J.317(7154), 307–312 (1998).
  • Tabar L, Vitak B, Yen MF et al. Number needed to screen: lives saved over 20 years of follow-up in mammographic screening. J. Med. Screen11(3), 126–129 (2004).
  • Silverstein MD, Pitts SR, Chaikof EL et al. Abdominal aortic aneurysm (AAA): cost-effectiveness of screening, surveillance of intermediate-sized AAA, and management of symptomatic AAA. Proc. (Bayl. Univ. Med. Cent.)18(4), 345–367 (2005).
  • Multicentre Aneurysm Screening Study Group. The Multicentre Aneurysm Screening Study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysm based on four year results from randomised controlled trial. Br. Med. J.325, 1135 (2002).
  • Hobbs S, Claridge M, Drage M et al. Strategies to improve the effectiveness of abdominal aortic aneurysm screening programmes. J. Med. Screen.11(2), 93–96 (2004).
  • Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants. Lancet352(9141), 1649–1655 (1998).
  • Lederle FA, Wilson SE, Johnson GR et al Aneurysm Detection and Management Veterans Affairs Cooperative Study Group. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N. Engl. J. Med.346(19), 1437–1444 (2002).
  • Scott RA, Thompson SG. Screening, surgical repair, and the management of abdominal aortic aneurisms. J. Med. Screen.12(2), 57–58 (2005).
  • Wilson KA, Woodburn KR, Ruckley CV et al. Expansion rates of abdominal aortic aneurysm: current limitations in evaluation. Eur. J. Vasc. Endovasc. Surg.13(6), 521–526 (1997).
  • Holmes DR, Petrinec D, Wester W et al. Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat. J. Surg. Res.63(1), 305–309 (1996).
  • Petrinec D, Liao S, Holmes DR et al. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J. Vasc. Surg.23(2), 336–346 (1996).
  • Petrinec D, Holmes DR, Liao S et al. Suppression of experimental aneurysmal degeneration with chemically modified tetracycline derivatives. Ann. NY Acad. Sci.800, 263–265 (1996).
  • Liao S, Miralles M, Kelley BJ et al. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. J. Vasc. Surg.33(5), 1057–1064 (2001).
  • Thompson RW, Baxter BT. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Ann. NY Acad. Sci.878, 159–178 (1999).
  • Lloyd GM, Newton JD, Norwood MG et al. Patients with abdominal aortic aneurysm: are we missing the opportunity for cardiovascular risk reduction? J. Vasc. Surg.40(4), 691–697 (2004).
  • Brook RH, Lohr KN. Efficacy, effectiveness, variations, and quality. Boundary-crossing research. Med. Care23(5), 710–722 (1985).
  • Lindsay SM, Duncan JL, Cairns J et al. Geography, private costs and uptake of screening for abdominal aortic aneurysm in a remote rural area. BMC Public Health6, 80 (2006).

Websites

  • Agency for Healthcare Research and Quality www.ahrq.gov/clinic/uspstfix.htm
  • Hayward Medical Communication evidence-based medicine. What is a QALY? www.evidence-based-medicine.co.uk
  • NHS breast screening programme annual review 2005 www.cancerscreening.nhs.uk
  • NHS cervical screening programme annual review 2005 www.cancerscreening.nhs.uk

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.